Matthias Feige studied Biochemistry at the Swiss Federal Institute of Technology (ETHZ) and the Technische Universität München (TUM), where he obtained his PhD in biochemistry. As a postdoctoral fellow at the St. Jude Children’s Research Hospital in Memphis, TN, USA, he expanded his research towards cell biology. In 2014 Matthias Feige was appointed as a Rudolf Mößbauer Tenure Track Professor at the TUM-IAS and now heads the laboratory for Cellular Protein Biochemistry at the TUM Department of Chemistry (cv).
Sabine Barbara Strasinsky obtained her training as a management assistant for office communication at the Klier GmbH and continued her education with a diploma in business administration from the University of Applied Sciences Munich. Babsi has profound expertise in administration and accounting which she obtained at Klier GmbH and Premiere/Sky Deutschland Fernsehen GmbH, where she worked as License Accountant for national and international contracts. In June 2021, Babsi joined the CPB lab and now heads the lab's administration as Team Assistant.
Nicolas Blömeke obtained his BSc in Biotechnology at the Hamburg University of Applied Sciences and continued his studies in Biochemistry at the TUM. During his Master thesis in the group of Stefan Jentsch at the Max Planck Institute of Biochemistry Nicolas was working on repair mechanisms of DNA-protein crosslinks. In October 2016 Nicolas joined the CPB lab to study quality control mechanisms of integral membrane proteins.
Anna Miesl obtained her training as a Chemical-Technical Assistant at the TUM Department of Chemistry in fields from macromolecular chemistry to protein biochemistry. In July 2017 Anna joined the CPB lab, managing and supporting our research projects. Anna's own research focusses on interleukins.
Karen Hildenbrand studied Biochemistry in Ulm, where she obtained her BSc. She continued her studies in Turku, Finland, and Munich. Karen performed her Master thesis in the CPB lab, working on the biogenesis of IL35 as an inhibitory IL12 family member. From February 2017 on Karen continues her studies on IL12 cytokines in our lab as a PhD student.
Sina Bohnacker obtained her Bachelor in Molecular Biotechnology at the TUM. Subsequently Sina continued her studies in Biochemistry at the TUM including a research stay at the Fondazione Edmund Mach in Italy. In 2018 Sina finished her Master thesis in the CPB lab, analyzing the structure and folding of IL23. Since January 2019, Sina is a PhD student in the CPB lab and the lab of Julia Esser-von Bieren (ZAUM), working on the biological functions of new immunomodulatory proteins.
Dinah Kaylani studied Biochemistry at the Technische Universität München (TUM). After her Bachelor thesis at the Werner Siemens Lehrstuhl für synthethische Biotechnologie (Prof. Dr. Thomas Brück) and research work at terraplasma medical GmbH and the DZIF, Dinah performed her Master thesis the CPB lab to investigate new mechanisms in membrane protein quality control. Since March 2020, Dinah is doing her PhD in the CPB lab to systematically investigate cellular quality control systems for membrane proteins.
Isabel Aschenbrenner obtained her Bachelor in Biochemistry at the TUM, performing her Bachelor thesis in the CPB lab on the biogenesis of IL23. Subsequently, Isabel continued her studies in Biochemistry at the TUM including a research stay at Concordia University in Montreal. In her Master thesis in the CPB lab Isabel analyzed the biogenesis, engineering and biological functions of IL27. In her PhD, which she began in April 2019, Isabel now works on IL12 and IL23 biogenesis, engineering and potential pharmacological targeting.
Kevin Meighen-Berger studied Biochemistry at the TU Munich. For his Bachelor thesis, he worked in Hendrik Dietz's lab on new DNA Origami structures. After further research work at the Institute of Medical Engineering, TUM, and terraplasma medical GmbH, Kevin pursued his Master thesis in the CPB lab where he focussed on a better understanding of membrane protein quality control by Calnexin. In March 2020 Kevin started his PhD in the CPB lab and is now aiming at a better understanding of the molecular and structural principles of membrane protein quality control.
Amelie Eichenseer obtained her training as a Biological-Technical Assistant at the TÜV Rheinland including a research stay at the TUM Medical Microbiology, Hygiene and Immunology Department in Markus Gerhard's group. In December 2020, Amelie joined the CPB lab to support the alphaSEPT team in the development of new immunomodulatory biopharmaceuticals.
Fabian Franke studied molecular biotechnology at the TUM including a research stay at the BioFarma-USEF Research Group at the University of Santiago de Compostela, Spain. Fabian did his PhD with Prof. Klaus-Peter Janssen in molecular tumor biology in the Department of Surgery of the Klinikum rechts der Isar (TUM). In July 2020, Fabian joined the CPB lab as protein scientist to develop new immunomodulatory biopharmaceuticals in the alphaSEPT team.
Korbinian Liebl studied Physics at the Technical University of Munich, where he also obtained his PhD in the group of Theoretical Biophysics of Prof Martin Zacharias. He joined the CPB lab in November 2020, and uses computational methods to investigate and engineer the biophysical basis of interleukin structure formation and assembly.
Carolin Klose obtained her Bachelor’s degree in Biochemistry at the TUM, completing her Bachelor’s thesis in the CPB lab on the biogenesis of IL23. Subsequently, Carolin joined the laboratory of Prof. Peter Walter at UCSF where she studied the integrated stress response and its role in memory formation. During her Master’s thesis in the laboratory of Prof. Franz-Ulrich Hartl at the Max Planck Institute of Biochemistry she analyzed cellular interactions of α-synuclein aggregates. In February 2021, Carolin joined the CPB lab to study structural and mechanistic principles of quality control for integral membrane proteins.
Johanna Pritzl obtained her training as a Chemical-Technical Assistant at the TUM Department of Chemistry. She worked in fields from protein biochemistry to structural biology and gained industrial experience at PharmaZell GmbH. In May 2021 Johanna joined the CPB lab to support our research on membrane proteins. Johanna's own research focusses on molecular machines and mechanisms of membrane protein biogenesis.
Sophia Hörl was trained as a Chemical-Technical Assistant at the TUM Department of Chemistry. She has gained experience in fields from NMR structural biology via protein biochemistry to synthetic approaches. In July 2021 Sophia joined the alphaSEPT team, where she develops approaches for protein expression, production and analysis.
Chantal Bergmann studied Biomolecular Engineering at the TU Darmstadt and performed her Bachelor thesis at Merck Healthcare under the supervision of Profs. Philip Hewitt and Harald Kolmar. She continued her studies in Darmstadt and performed her Master thesis with Prof. Schmitz on the development of a new fibrinogen quick test for clinical applications. During her studies, Chantal has gained broad experience in academic research from organoid biology to cellular protein degradation tools as well as in industrial research. In August 2021, Chantal joined the CPB lab to work on the engineering, structural and immunological analysis of new human interleukins.